Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

Unlocking Shareholder Value as Milestones Approach: Uplisting in 2014

January 6th, 2014

Fortune favors the prepared mind – Louis Pasteur

"We are eagerly preparing an exciting 2014 for the Company, as we ended 2013 in excellent position having completed a number of business development 'transactions that significantly improve the commercial potential of our MANF program. Over the last four weeks the Company has also made significant internal improvements as we prepare to meet the requirements to up-list in 2014. We believe we are in excellent position as LymPro and MANF are set to achieve significant milestones in the first half of 2014."

- See more at:

http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/unlocking-shareholder-value-milestones-approach-uplisting-2014/#sthash.BPYFWfs6.dpuf

_____________________________________________________________________________________________________________________

can't help but think there are any number of big catalysts that will propell this security to new all time highs going into the NASDAQ uplisting...

1.) JV on LymPro
2.) potential sale of Diagnostics Div
3.) potential JV w/J&J on Phenoguard Cell Line
4.) new acquisition candidate

...interesting that the shares underlying the last 173-Mil. tranche have not been registered. Is AMBS already close to securing the additional $5-Mil. funding through other avenues, possible grant funding as one?